BioWisdom Makes its SRS 3D Technology Available for Free

BioWisdom Ltd (BioWisdom) has announced the release of its SRS 3D technology as free software under the GNU General Public License version two (GPLv2).

The company says that SRS is a scalable and robust data integration platform that can provide fast access to diverse life sciences information including genetic, protein, expression, pathway, molecular and clinical data from public and proprietary sources, regardless of data format.

SRS is a bioinformatics data integration, providing global bioinformatics platforms to pharmaceutical companies including GSK, Eli Lilly, Merck and Co, and Pfizer.

SRS 3D is a module of BioWisdom’s SRS system that can enable the integration and display of sequences and annotations together with 3D structures. The details are available at http://www.SRS3D.org, a site hosted by the European Molecular Biology Laboratory (EMBL).

“SRS 3D is one of the most useful and intuitive systems for presenting sequence features on 3D structures.” said Dr Reinhard Schneider, Group Leader in the Structural and Computational Biology Unit at EMBL. “Making SRS 3D available free to everyone will enable the scientific community to improve how 3D-related information is communicated.

“Making SRS 3D freely available as an open source shortly after launching our OmniViz academic program is a reflection of our continued commitment to supporting the work of the academic community,” said Dr Gordon Baxter, CEO of BioWisdom. “SRS users now have access to a leading tool for visualizing protein structures in SRS.”